Skip to content

Clinical trials

Phase 1 Anemia, Refractory, with Excess of Blasts trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anemia, Refractory, with Excess of Blasts Phase: Phase 1 Country / region: United States Clear all

60 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20007
20011
20024
20032
20045
20057
20062
20075
20081
20091
20102
20121
20141
20162
20171
20181
20191
20201
20221
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed46
Terminated12
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)10
Fred Hutchinson Cancer Center6
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins6
Memorial Sloan Kettering Cancer Center4
M.D. Anderson Cancer Center3
Vion Pharmaceuticals3
Case Comprehensive Cancer Center2
Dana-Farber Cancer Institute2
Massachusetts General Hospital2
AbbVie (prior sponsor, Abbott)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia, Refractory, with Excess of Blasts60
Leukemia, Myeloid, Acute38
Leukemia33
Myelodysplastic Syndromes33
Precursor Cell Lymphoblastic Leukemia-Lymphoma30
Leukemia, Myelomonocytic, Chronic29
Congenital Abnormalities19
Leukemia, Lymphocytic, Chronic, B-Cell19
Blast Crisis18
Myeloproliferative Disorders17

Trials

Showing 1 to 25 of 60. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.